AIMS: Our purpose was to report the clinical and pathological findings from uveal melanoma patients with persistent exudative retinal detachment (RD) after Gamma Knife radiosurgery (GKR). METHODS: A retrospective review was performed. RESULTS: GKR was performed on 19 uveal melanoma patients from 2004 to 2006, and 5 of them developed persistent exudative RD. The mean initial largest basal tumor diameter in these 5 patients was 14.4 +/- 1.9 mm, and the mean tumor height was 9.2 +/- 1.0 mm. Marginal doses of 40-50 Gy radiation were administered. RD developed or had become aggravated an average of 3 (1-10) months after GKR. Two patients underwent enucleation, while the remaining 3 underwent tumor removal by endoresection with retinal reattach...
PURPOSE: To report local disease control and all-cause mortality in patients with extraocular extens...
Most uveal melanomas are treated with radiotherapy. An adequate understanding of the effects of radi...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
We present the outcomes of 35 uveal melanoma patients treated with gamma knife stereotactic radiosur...
OBJECT: Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality...
We report on 36 cases of uveal melanoma treated at our center between March 1993 and September 1995....
AIM: To report on trans-scleral local resection of choroidal melanoma for exudative retinal detachme...
Abstract Background This study retrospectively analyzed outcomes for patients undergoing gamma knife...
PURPOSE: To determine the rate of retinal detachment after treatment of retinoblastoma, to describe ...
PURPOSE: To analyze the long-term results of eye retention after conservative treatment of uveal mel...
Abstract Background For the majority of eyes with choroidal melanoma, radiation therapy is the treat...
BACKGROUND AND OBJECTIVE: To evaluate the effectiveness of Leksell Gamma Knife stereotactic radio-su...
Objective: To report on the incidence and outcome of rhegmatogenous retinal detachment after transsc...
Uveal melanoma is a rare disease causing significant mortality. Metastatic disease - for which there...
OBJECTIVE: To report the development of retinal break or rhegmatogenous retinal detachment (RRD) aft...
PURPOSE: To report local disease control and all-cause mortality in patients with extraocular extens...
Most uveal melanomas are treated with radiotherapy. An adequate understanding of the effects of radi...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
We present the outcomes of 35 uveal melanoma patients treated with gamma knife stereotactic radiosur...
OBJECT: Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality...
We report on 36 cases of uveal melanoma treated at our center between March 1993 and September 1995....
AIM: To report on trans-scleral local resection of choroidal melanoma for exudative retinal detachme...
Abstract Background This study retrospectively analyzed outcomes for patients undergoing gamma knife...
PURPOSE: To determine the rate of retinal detachment after treatment of retinoblastoma, to describe ...
PURPOSE: To analyze the long-term results of eye retention after conservative treatment of uveal mel...
Abstract Background For the majority of eyes with choroidal melanoma, radiation therapy is the treat...
BACKGROUND AND OBJECTIVE: To evaluate the effectiveness of Leksell Gamma Knife stereotactic radio-su...
Objective: To report on the incidence and outcome of rhegmatogenous retinal detachment after transsc...
Uveal melanoma is a rare disease causing significant mortality. Metastatic disease - for which there...
OBJECTIVE: To report the development of retinal break or rhegmatogenous retinal detachment (RRD) aft...
PURPOSE: To report local disease control and all-cause mortality in patients with extraocular extens...
Most uveal melanomas are treated with radiotherapy. An adequate understanding of the effects of radi...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...